Dr. Amit Kumar, MD

Dr. Kumar practices at Ochsner Lafayette General Medical Center in Lafayette, Louisiana, part of Ochsner Health System.

Dr. Kumar's NPI, 1790834950, was assigned on January 9, 2007. Dr. Kumar holds Kansas license 0431424.

Dr. Kumar's primary practice is Ochsner Lafayette General Medical Center, at 1214 Coolidge Avenue, Lafayette, LA 70503 in Lafayette Parish. The practice phone is (337) 289-7991.

Dr. Kumar's primary practice is Ochsner Lafayette General Medical Center in Lafayette, Louisiana, part of Ochsner Health System. Dr. Kumar is also affiliated with Ochsner St. Martin Hospital. The medical group on file is Cardiovascular Institute of the South. Dmand AI also links Dr. Kumar to 3 more hospitals, 5 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kumar is licensed in Kansas.

CMS data shows 4,433 Medicare services from Dr. Kumar across 14 procedure codes in 2024, for 2,631 Medicare patients. Medicare paid $125,404 for them.

CMS counts 2,631 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 963 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 67, with 52% women.

In 2024, Dr. Kumar wrote 75 Medicare Part D claims for 13 patients. 97% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $151 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links Dr. Kumar to 2 clinical trials. Conditions studied include Peripheral Arterial Disease, Rhabdomyosarcoma, Alveolar and Myosarcoma. C. R. Bard sponsors the most, 2. Open Payments lists research payments to Dr. Kumar that name 2 trials.

CMS Open Payments shows 173 general payments to Dr. Kumar from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abiomed paid the most, $688. It also lists 2 research payments totaling $4,870 in 2016, naming 2 clinical trials.